7WCP
BMY icon

71 West Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

71 West Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$681K Buy
11,235
+735
+7% +$42.8K 0.03% 127
2025
Q4 		$566K Buy
+10,500
New +$505K 0.03% 126

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

71 West Capital Partners's BMY Position: Q1 2026 in Review

71 West Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2026, buying an estimated $42.8K and bringing the position to 11,235 shares worth $681K. The position accounts for 0.03% of the portfolio, ranked #127.

71 West Capital Partners first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • 71 West Capital Partners held 11,235 shares of Bristol-Myers Squibb worth $681K as of Q1 2026.
  • 71 West Capital Partners bought 735 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.8K.
  • Bristol-Myers Squibb made up 0.03% of 71 West Capital Partners's portfolio in Q1 2026, its #127 holding.
  • 71 West Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on 71 West Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.